AVITA Medical (AVHHL) Net Cash Flow Growth (3y) (2022 - 2025)
Powered by 
Analysis
AVITA Medical (AVHHL) Net Cash Flow Growth (3y) (2022 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.92 Bn | 179.32 Bn | 7.27 Bn | -9.45% |
| 2 | Intuitive Surgical | 124.64 Bn | 119.43 Bn | 1.96 Bn | -16.59% |
| 3 | Medtronic | 118.74 Bn | 109.92 Bn | 6.34 Bn | -0.80% |
| 4 | Stryker | 104.84 Bn | 101.36 Bn | 4.50 Bn | 60.16% |
| 5 | Boston Scientific | 67.36 Bn | 66.82 Bn | 3.85 Bn | -85.83% |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn | 43.26% |
| 7 | Alcon | 33.93 Bn | 32.48 Bn | 1.68 Bn | 1.60% |
| 8 | Dexcom | 32.38 Bn | 30.43 Bn | 830.00 Mn | -26.30% |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 269.22% |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -104.41% |
| Mar 31, 2025 | 26.53% |
| Dec 31, 2024 | 58.58% |
| Sep 30, 2024 | 16.54% |
| Jun 30, 2024 | 26.79% |
| Mar 31, 2024 | -27.93% |
| Dec 31, 2023 | -68.38% |
| Sep 30, 2023 | 54.26% |
| Jun 30, 2023 | 52.99% |
| Mar 31, 2023 | 48.81% |
| Dec 31, 2022 | -26.17% |